Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    15032581 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer
Conditions: Sarcoma;   Wilm's Tumor;   Lymphoma;   Neuroblastoma
Intervention: Drug: Ipilimumab

Study has passed its completion date and status has not been verified in more than two years.